XSHE
300326
Market cap575mUSD
Dec 05, Last price
5.67CNY
1D
0.71%
1Q
1.43%
Jan 2017
-49.01%
IPO
32.38%
Name
Shanghai Kinetic Medical Co Ltd
Chart & Performance
P/E
—
P/S
4.13
EPS
—
Div Yield, %
1.06%
Shrs. gr., 5y
-0.13%
Rev. gr., 5y
-4.23%
Revenues
985m
+2.96%
Net income
-106m
L
CFO
158m
-42.48%
Dividend
Jul 16, 20240.06 CNY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Shanghai Kinetic Medical Co., Ltd manufactures and sells medical devices in China and internationally. It provides products for multidisciplinary specialties, including orthopedics, cardiovascular, and sports medicine. The company offers primom spinal fixation system, a system of instruments and implants designed to treat modern deformity, degenerative, and trauma applications; kyphoplasty systems; vertebral osteotome for cavity creation or working pathway establishment in vertebral body; bone cement delivery systems for distance bone cement delivery; injection guns for bone cement injection; and multifunctional tools for insertion and working pathway set-up. It also provides kinect locking compression plate systems. The company was founded in 2005 and is based in Shanghai, China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||